Antitrust Class Actions Against CVS, Other Pharmacy Benefit Managers Are Piling Up
Plaintiffs, independent pharmacies, claimed the defendants "have vertically integrated" with health care giants such as insurance companies, health care providers, drug private labelers and others. As a result, the complaints say, pharmacy benefits managers use anticompetitive methods to suppress reimbursements for discount card payments, which allegedly causes stand-alone pharmacies to suffer and even go out of business.
Litigation Surge: Drugmakers Launch Flood of Suits to Halt Generics
At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers' plans to sell lower-priced versions of recognized pharmaceutical products.